A possible reason was that 72.4% of NEC + MANEC patients presented with distant metastases, which might result in higher serum CgA levels, while only 48.2% of NET patients presented distant metastases. The gene discussed is CGA; the disease is digestive system mixed adenoneuroendocrine carcinoma.